June 2017 - Volume 23 - Issue 6
pp: 853-1046,E38-E40

Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease

Yadav, Abhijeet; Foromera, Joshua; Feuerstein, Ilana; More

Inflammatory Bowel Diseases . 23(6):853-857, June 2017.

Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease

Nguyen, Geoffrey C.; Boland, Karen; Afif, Waqqas; More

Inflammatory Bowel Diseases . 23(6):858-865, June 2017.

Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011

Narula, Neeraj; Borges, Lawrence; Steinhart, A. Hillary; More

Inflammatory Bowel Diseases . 23(6):868-874, June 2017.

Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database

Barnes, Edward L.; Kochar, Bharati; Long, Millie D.; More

Inflammatory Bowel Diseases . 23(6):875-881, June 2017.

Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide

Heida, Anke; Park, K. T.; van Rheenen, Patrick F.

Inflammatory Bowel Diseases . 23(6):894-902, June 2017.

Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis

Jacob, Vinita; Crawford, Carl; Cohen-Mekelburg, Shirley; More

Inflammatory Bowel Diseases . 23(6):903-911, June 2017.

Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis

Günaltay, Sezin; Repsilber, Dirk; Helenius, Gisela; More

Inflammatory Bowel Diseases . 23(6):932-945, June 2017.

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Coulthard, Sally A.; Berry, Phil; McGarrity, Sarah; More

Inflammatory Bowel Diseases . 23(6):946-955, June 2017.

Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease

Walters, Thomas D.; Faubion, William A.; Griffiths, Anne M.; More

Inflammatory Bowel Diseases . 23(6):967-975, June 2017.

Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease

Pauly, Nathan J.; Michailidis, Lamprinos; Kindred, Michael G.; More

Inflammatory Bowel Diseases . 23(6):1004-1010, June 2017.

Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective...

Hata, Keisuke; Ishii, Hiroaki; Anzai, Hiroyuki; More

Inflammatory Bowel Diseases . 23(6):1019-1024, June 2017.

Imaging in Patients with Crohn's Disease: Trends in Abdominal CT/MRI Utilization and Radiation Exposure Considerations over a 10-Year Period

Kordbacheh, Hamed; Baliyan, Vinit; Serrao, Jessica; More

Inflammatory Bowel Diseases . 23(6):1025-1033, June 2017.

Early Life Exposure, Lifestyle, and Comorbidity as Risk Factors for Microscopic Colitis: A Case–Control Study

Verhaegh, Bas P. M.; Pierik, Marieke J.; Goudkade, Danny; More

Inflammatory Bowel Diseases . 23(6):1040-1046, June 2017.

Letters to the Editor

1 2 3 4 5